Sander Pajusalu

Dr. Sander Pajusalu

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
WLWei Liu
Wei Liu
SPSander Pajusalu
Sander Pajusalu
NLNicole J. Lake
Nicole J. Lake
GZGeyu Zhou
Geyu Zhou
NINilah Ioannidis
Nilah Ioannidis
MLMonkol Lek
Monkol Lek

2 June 2016 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
KRKarit Reinson
Karit Reinson
EÕEve Õiglane‐Shlik
Eve Õiglane‐Shlik
ITInga Talvik
Inga Talvik
UVUlvi Vaher
Ulvi Vaher
AÕAnne Õunapuu
Anne Õunapuu
KOKatrin Ounap
Katrin Ounap

26 April 2016 in Neurology
Verified
Journal Article
Closed access
PDF file
RPRoberta La Piana
Roberta La Piana
FCFerdy K. Cayami
Ferdy K. Cayami
LTLuan T. Tran
Luan T. Tran
KGKether Guerrero
Kether Guerrero
RSRosalina van Spaendonk
Rosalina van Spaendonk
GBGeneviève Bernard
Geneviève Bernard
Objective: To report atypical MRI patterns associated with POLR3A and POLR3B mutations. Methods: This was a multicenter retrospective study to collect neuroradiologic, clinical, and molecular data of patients with mutations in POLR3A and POLR3B without the classic MRI phenotype, i.e., diffuse hypomyelination associated with relative T2 hypointensity of the ventrolateral thalamus, globus pallidus, optic radiation, corticospinal tract at the level of the internal capsule, and dentate nucleus, cerebellar atrophy, and thinning of the corpus callosum. Results: Eight patients were identified: 6 carried mutations in POLR3A and 2 in POLR3B. We identified 2 novel MRI patterns: 4 participants presented a selective involvement of the corticospinal tracts, specifically at the level of the posterior limbs of the internal capsules; 4 patients presented moderate to severe cerebellar atrophy. Incomplete hypomyelination was observed in 5 participants. Conclusion: Diffuse hypomyelination is not an obligatory feature of POLR3-related disorders. Two distinct patterns, selective involvement of the corticospinal tracts and cerebellar atrophy, are added to the MRI presentation of POLR3-related disorders.

18 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
MOMonika Oláhová
Monika Oláhová
BPBradley Peter
Bradley Peter
ZSZsolt Szilagyi
Zsolt Szilagyi
HDHector Diaz-Maldonado
Hector Diaz-Maldonado
MSMeenakshi Singh
Meenakshi Singh
RTRobert W. Taylor
Robert W. Taylor
While >300 disease-causing variants have been identified in the mitochondrial DNA (mtDNA) polymerase γ, no mitochondrial phenotypes have been associated with POLRMT, the RNA polymerase responsible for transcription of the mitochondrial genome. Here, we characterise the clinical and molecular nature of POLRMT variants in eight individuals from seven unrelated families. Patients present with global developmental delay, hypotonia, short stature, and speech/intellectual disability in childhood; one subject displayed an indolent progressive external ophthalmoplegia phenotype. Massive parallel sequencing of all subjects identifies recessive and dominant variants in the POLRMT gene. Patient fibroblasts have a defect in mitochondrial mRNA synthesis, but no mtDNA deletions or copy number abnormalities. The in vitro characterisation of the recombinant POLRMT mutants reveals variable, but deleterious effects on mitochondrial transcription. Together, our in vivo and in vitro functional studies of POLRMT variants establish defective mitochondrial transcription as an important disease mechanism.

26 June 2019 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
EKEnrico D. H. Konrad
Enrico D. H. Konrad
NNNiels Nardini
Niels Nardini
ACAlmuth Caliebe
Almuth Caliebe
INInga Nagel
Inga Nagel
DYDana Young
Dana Young
CZChristiane Zweier
Christiane Zweier
Purpose Pathogenic variants in the chromatin organizer CTCF were previously reported in seven individuals with a neurodevelopmental disorder (NDD). Methods Through international collaboration we collected data from 39 subjects with variants in CTCF. We performed transcriptome analysis on RNA from blood samples and utilized Drosophila melanogaster to investigate the impact of Ctcf dosage alteration on nervous system development and function. Results The individuals in our cohort carried 2 deletions, 8 likely gene-disruptive, 2 splice-site, and 20 different missense variants, most of them de novo. Two cases were familial. The associated phenotype was of variable severity extending from mild developmental delay or normal IQ to severe intellectual disability. Feeding difficulties and behavioral abnormalities were common, and variable other findings including growth restriction and cardiac defects were observed. RNA-sequencing in five individuals identified 3828 deregulated genes enriched for known NDD genes and biological processes such as transcriptional regulation. Ctcf dosage alteration in Drosophila resulted in impaired gross neurological functioning and learning and memory deficits. Conclusion We significantly broaden the mutational and clinical spectrum ofCTCF-associated NDDs. Our data shed light onto the functional role of CTCF by identifying deregulated genes and show that Ctcf alterations result in nervous system defects in Drosophila.

22 January 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
DBDavid B Beck
David B Beck
MBMohammed A. Basar
Mohammed A. Basar
AAAnthony J. Asmar
Anthony J. Asmar
JTJoyce J. Thompson
Joyce J. Thompson
HOHirotsugu Oda
Hirotsugu Oda
AWAchim Werner
Achim Werner
Reversible modification of proteins with linkage-specific ubiquitin chains is critical for intracellular signaling. Information on physiological roles and underlying mechanisms of particular ubiquitin linkages during human development are limited. Here, relying on genomic constraint scores, we identify 10 patients with multiple congenital anomalies caused by hemizygous variants in OTUD5, encoding a K48/K63 linkage–specific deubiquitylase. By studying these mutations, we find that OTUD5 controls neuroectodermal differentiation through cleaving K48-linked ubiquitin chains to counteract degradation of select chromatin regulators (e.g., ARID1A/B, histone deacetylase 2, and HCF1), mutations of which underlie diseases that exhibit phenotypic overlap with OTUD5 patients. Loss of OTUD5 during differentiation leads to less accessible chromatin at neuroectodermal enhancers and aberrant gene expression. Our study describes a previously unidentified disorder we name LINKED (LINKage-specific deubiquitylation deficiency–induced Embryonic Defects) syndrome and reveals linkage-specific ubiquitin cleavage from chromatin remodelers as an essential signaling mode that coordinates chromatin remodeling during embryogenesis.